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Hepatitis E Virus 
Genotype 4,  
Denmark, 2012
To the Editor: Hepatitis E virus 
genotype 4 (HEV4) is most commonly 
reported in China and Japan; it has pri-
marily been categorized as a zoonotic 
virus because it has been found in hu-
mans and several other animal species 
(1). In Europe, HEV4 has been iden-
tified in 6 countries, in humans and 
other animals. The first cases of HEV4 
infection in a human and an animal 
(pig) were detected through strain 
surveillance activities in Germany 
(2) and Belgium (3), respectively. In 
May 2009, France reported an isolated 
case of HEV4 infection in a human; 
however, the source of infection could 
not be determined. Consumption of 
contaminated food was deemed un-
likely, but receipt of contaminated 
blood during transfusion was possible 
(4). In 2011, an outbreak of HEV4 in 
France was associated with consump-
tion of figatelli, a liver sausage that is 
traditionally consumed uncooked (5). 
Also in 2011, an outbreak in Italy was 
reported, in which contaminated water 
was suggested as a possible source of 
infection (6). HEV4 has also been de-
tected in a patient in the United King-
dom. This patient, however, had just 
returned from India, so the infection 
was associated with travel (7). Trans-
mission was suspected to be zoonotic 
because the sequence was most closely 
related to isolates from swine in India.
From January 2010 through De-
cember 2012, the Department of 
Microbiological Diagnostics and Vi-
rology of the Statens Serum Institut 
received 1,112 samples from 823 pa-
tients with clinically suspected hepa-
titis for HEV diagnostic serologic and 
PCR testing. Blood samples were test-
ed for HEV IgM and IgG by use of the 
DS-EIA-ANTI-HEV-M and DS-EIA-
ANTI-HEV-G kits (DSI, Saronno, 
Italy) according to the manufacturer’s 
instructions. Diagnostic real-time 
reverse transcription PCR (RT-PCR) 
amplifying a 79-bp fragment of open 
reading frame 3 (8) was conducted by 
using a QIAGEN OneStep RT-PCR 
Kit (Hilden, Germany). Samples from 
59 (7%) patients were HEV posi-
tive according to serologic testing; 
of these, 20 (34%) were positive for 
HEV RNA according to RT-PCR.
Genotyping was conducted by 
amplifying 804 bp of open reading 
frame 2. By sequencing of PCR prod-
ucts, 13 (65%) samples were success-
fully genotyped; 3 in 2010, 7 in 2011, 
and 3 in 2012. In 2010 and 2011, 
HEV genotypes 3 and 1, respectively, 
were detected in 5 patients. In 2012, a 
total of 3 patients were infected with 
HEV genotype 4. 
The 3 sequences obtained in 
this study (GenBank accession nos. 
KC928081–KC928083) were sub-
jected to phylogenetic analysis, along 
with reference sequences that includ-
ed the sequences from the France and 
Italy outbreaks and the strain from 
the HEV4 virus identified in a pig in 
Belgium in 2008. All sequences were 
aligned by using the Simmonic se-
quence editor (9). Phylogenetic trees 
were constructed by using MEGA5 
(10) with the maximum-likelihood 
method and the Jukes-Cantor algo-
rithm with 500 bootstrap replicates.
Of the 3 patients from Denmark, 
the HEV4 sequence from 1 patient 
(March 2012) resembled the sequence 
from Italy, and these 2 strains grouped 
together with strains from humans and 
other animals from China (Figure). 
This patient reported having traveled 
to China; thus, zoonotic infection ac-
quired while abroad is suggested. The 
other 2 patients from Denmark (June 
2012) reported no travel history, and 
the viruses detected in these patients 
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were almost identical; only 2 nt differ-
ences were found. No epidemiologic 
or geographic link connected these 2 
patients. The only link was the date of 
sample collection. Both patients were 
ill during the summer, which sug-
gests possible consumption of under-
cooked, or raw, contaminated food as 
the source of infection. The sequences 
from these 2 patients were most closely 
related to the sequences from patients 
involved in the outbreaks in France 
(Figure). These sequences all form a 
group with the HEV4 virus identified 
in the pig in Belgium in 2008, thereby 
suggesting a zoonotic origin.
Because Statens Serum Institut is 
the only laboratory in Denmark that 
offers diagnostic testing for HEV, we 
consider our national surveillance to 
be fairly complete. Prospective sur-
veillance will show whether HEV4 
becomes established within Denmark. 
To date, HEV4 has not been detected 
in animal populations in Denmark. In 
China, similarity of HEV4 data be-
tween strains from humans and other 
animals in the same geographic areas 
was high, which is highly suggestive 
of zoonotic transmission (3). Be-
cause of the rare detection of HEV4 
in Europe, these types of data are not 
yet available for European countries. 
However, the close phylogenetic re-
lationship between the strains from 
humans in Denmark and France and 
the strain from the pig in Belgium 
suggests a zoonotic origin for this 
genotype in these countries. This sug-
gestion is further supported by the fact 
that some of the strains from France 
were associated with the consumption 
of pork liver sausage. 
The emergence of autochtho-
nous HEV4 infection in human 
populations in 4 European countries, 
and its detection in different years 
(2006/2007, 2008, 2009, 2011, and 
2012), suggests that this genotype 
may be established in Europe. Thus, 
for the purpose of ensuring HEV4 
detection, diagnostic and genotyping 
methods should be evaluated.
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To the Editor: Tour leaders ac-
company and care for the health, com-
fort, and safety of travelers in group 
tours, which remain a popular method 
of international travel in Asian coun-
tries, including Taiwan (1). In addi-
tion to travel agents and physicians, 
tour leaders can also play a key role 
in the prevention and management of 
travel-related infectious diseases dur-
ing group tours.
Rabies is a viral, vaccine-prevent-
able, zoonotic, infectious disease that 
occurs throughout the world; it is al-
most always fatal (2, 3). According to 
records of postexposure prophylaxis, 
≈0.4% of all travelers have experi-
enced 1 animal (at-risk) bite per month 
of stay in a rabies-endemic country; in 
the past 10 years, at least 22 confirmed 
cases of rabies among travelers have 
been reported (4,5). Given that ra-
bies-endemic countries include many 
popular tourist destinations, rabies 
has become one of the most serious 
travel-related infectious diseases (3). 
In 2011, nearly half of the 9 million 
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